Skip to main content

Table 2 Immunohistochemical staining of ERGIC3 in lung cancer tissues

From: Suppression subtractive hybridization identified differentially expressed genes in lung adenocarcinoma: ERGIC3as a novel lung cancer-related gene

Characteristic ERGIC3 ERGIC3+ P-value
Gender    0.279
 Male 3/17 (18%)# 14/17 (82%)  
 Female 1/18 (6%) 17/18 (94%)  
Age, y    /
 Median 55.9 53.5  
 Range 36-76 38-71  
Smoking    0.323
 No 1/17 (6%) 16/17 (94%)  
 Yes 3/18 (17%) 15/18 (83%)  
Histological type    0.014*
 AC 0 22/22 (100%)  
 SCC 4/13 (31%) 9/13 (69%)  
TNM stage    0.419
 I + II 3/20 (15%) 17/20 (85%)  
 III + IV 1/15 (7%) 14/15 (93%)  
Differentiation    0.006*
 Poor 4/11 (36%) 7/11 (64%)  
 Well or Moderate 0 24/24 (100%)  
  1. Statistical significance was determined by the Fisher’s exact test of chi-square test (two-tailed); #: Number of cases applicable/total number of cases examined (with percent in parenthesis); *: Statistically significant, P < 0.05.
  2. Abbreviations: SCC: squamous cell carcinoma; AC: adenocarcinoma; y: year.